As of 2025-04-24, the Intrinsic Value of agilon health Inc (AGL) is 18.82 USD. This AGL valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 4.04 USD, the upside of agilon health Inc is 365.80%.
The range of the Intrinsic Value is 12.94 - 31.85 USD
Based on its market price of 4.04 USD and our intrinsic valuation, agilon health Inc (AGL) is undervalued by 365.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (1.74) - (1.57) | (1.63) | -140.3% |
| DCF (Growth 10y) | 12.94 - 31.85 | 18.82 | 365.8% |
| DCF (EBITDA 5y) | 7.85 - 10.05 | 9.18 | 127.2% |
| DCF (EBITDA 10y) | 20.41 - 27.49 | 24.27 | 500.7% |
| Fair Value | -3.15 - -3.15 | -3.15 | -178.09% |
| P/E | (13.41) - (12.87) | (13.76) | -440.5% |
| EV/EBITDA | (6.03) - (6.81) | (6.53) | -261.7% |
| EPV | (4.22) - (5.70) | (4.96) | -222.8% |
| DDM - Stable | (6.04) - (17.25) | (11.65) | -388.2% |
| DDM - Multi | 10.59 - 23.82 | 14.70 | 263.9% |
| Market Cap (mil) | 1,665.69 |
| Beta | 0.63 |
| Outstanding shares (mil) | 412.30 |
| Enterprise Value (mil) | 1,512.37 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.30% |
| Cost of Debt | 8.49% |
| WACC | 7.32% |